Back to Search
NORMAN CHANG, M.D.
M.D.
Internal Medicine Physician
NPI: 1629064605IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
0101058399(VA)
CMS Specialties
PrimaryINTERNAL MEDICINE
Education
MEDICAL COLLEGE OF GEORGIA SCHOOL OF MEDICINE
Class of 1995
Research & Publications (20)
WOX1 is essential for tumor necrosis factor-, UV light-, staurosporine-, and p53-mediated cell death, and its tyrosine 33-phosphorylated form binds and stabilizes serine 46-phosphorylated p53.
PMID 16219768·J Biol Chem·2005
7-preclinical
JNK1 physically interacts with WW domain-containing oxidoreductase (WOX1) and inhibits WOX1-mediated apoptosis.
PMID 12514174·J Biol Chem·2003
7-preclinical
Reviewing case reports and the droperidol warning: FDA response.
PMID 14570686·Anesth Analg·2003
8-other
Transforming growth factor-beta1 blocks the enhancement of tumor necrosis factor cytotoxicity by hyaluronidase Hyal-2 in L929 fibroblasts.
PMID 11960552·BMC Cell Biol·2002
7-preclinical
The non-ankyrin C terminus of Ikappa Balpha physically interacts with p53 in vivo and dissociates in response to apoptotic stress, hypoxia, DNA damage, and transforming growth factor-beta 1-mediated growth suppression.
PMID 11799106·J Biol Chem·2002
7-preclinical
Hyaluronidase induction of a WW domain-containing oxidoreductase that enhances tumor necrosis factor cytotoxicity.
PMID 11058590·J Biol Chem·2001
7-preclinical
Hyaluronidase activation of c-Jun N-terminal kinase is necessary for protection of L929 fibrosarcoma cells from staurosporine-mediated cell death.
PMID 11327694·Biochem Biophys Res Commun·2001
7-preclinical
TGF-beta-induced matrix proteins inhibit p42/44 MAPK and JNK activation and suppress TNF-mediated IkappaBalpha degradation and NF-kappaB nuclear translocation in L929 fibroblasts.
PMID 10623598·Biochem Biophys Res Commun·2000
7-preclinical
Suppression of IkappaBalpha expression is necessary for c-Jun N-terminal kinase-mediated enhancement of Fas cytotoxicity.
PMID 10903887·Biochem Biophys Res Commun·2000
7-preclinical
Bragg cell laser intensity modulation: effect on laser Doppler velocimetry measurements.
PMID 19543356·Appl Opt·2009
8-other
Ray-based acoustic localization of cavitation in a highly reverberant environment.
PMID 19425652·J Acoust Soc Am·2009
8-other
Granulocyte colony-stimulating factor increases sympathetic reinnervation and the arrhythmogenic response to programmed electrical stimulation after myocardial infarction in rats.
PMID 19502563·Am J Physiol Heart Circ Physiol·2009
7-preclinical
Complement C1q activates tumor suppressor WWOX to induce apoptosis in prostate cancer cells.
PMID 19484134·PLoS One·2009
8-other
Cab45b, a Munc18b-interacting partner, regulates exocytosis in pancreatic beta-cells.
PMID 19487699·J Biol Chem·2009
7-preclinical
Characterization of the dominant molecular step orientations on hydroxyapatite (100) surfaces.
PMID 19496551·Langmuir·2009
8-other
Assessment of changes in knowledge and stigmatization following tuberculosis training workshops in taiwan.
PMID 19443291·J Formos Med Assoc·2009
8-other
The Mothers and Children's Environmental Health (MOCEH) study.
PMID 19629723·Eur J Epidemiol·2009
8-other
Systemic and local reactions of a water-soluble copolymer bone on a bony defect of rabbit model.
PMID 19665194·Surg Neurol·2009
7-preclinical
Primary vaginal extraosseous Ewing sarcoma/primitive neuroectodermal tumor with cranial metastasis.
PMID 19541570·J Chin Med Assoc·2009
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 611 JEFFERSON DAVIS HWY, SUITE 201
FREDERICKSBURG, VA 22401 - Phone
- (540) 371-4141
Quick Facts
- NPI
- 1629064605
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 31
- Publications
- 20
Are you this provider?
Claim Your Profile